# Role of the Microbiota in the Evolution of the SARS-CoV-2 Disease,COVID-19, in Hospitalized Patients

> **NCT04669938** · — · UNKNOWN · sponsor: **Assistance Publique - Hôpitaux de Paris** · enrollment: 200 (estimated)

## Conditions studied

- Covid19

## Interventions

- **OTHER:** oropharyngeal and intestinal microbiota
- **OTHER:** host genotype
- **OTHER:** host immune factors
- **OTHER:** viral sequence

## Key facts

- **NCT ID:** NCT04669938
- **Lead sponsor:** Assistance Publique - Hôpitaux de Paris
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-12-04
- **Primary completion:** 2021-12-04
- **Final completion:** 2022-08-31
- **Target enrollment:** 200 (ESTIMATED)
- **Last updated:** 2022-06-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04669938

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04669938, "Role of the Microbiota in the Evolution of the SARS-CoV-2 Disease,COVID-19, in Hospitalized Patients". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT04669938. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*